Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12-week, Randomised, Double Blind, Active-controlled, Multi-centre, Phase IIIB Study Comparing the Efficacy and Safety of SYMBICORT® pMDI 160/4.5 mg x 2 Actuations Twice Daily Versus Budesonide HFA pMDI 160 mg x 2 Actuations Twice Daily, in Adult/Adolescent (> 12 Yrs) Hispanic Subjects With Asthma
Brief Summary: The purpose of this study is to determine the effectiveness and safety of SYMBICORT® pMDI (a medication approved by the Food and Drug Administration(FDA)) in the Hispanic population.


Options:
A: Arm Label: Symbicort; Type: ACTIVE_COMPARATOR; Interventions: Drug: Budesonide/formoterol (SYMBICORT) pMDI | Arm Label: Budesonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Budesonide HFA pMDI | Intervention Type: DRUG; Name: Budesonide/formoterol (SYMBICORT) pMDI; Assigned to Arm(s): Symbicort | Intervention Type: DRUG; Name: Budesonide HFA pMDI; Assigned to Arm(s): Budesonide
B: Arm Label: Crossover sequence 1; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 2; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 3; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 4; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 5; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 6; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 7; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 8; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Intervention Type: DRUG; Name: Flovent Diskus® 100 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4 | Intervention Type: DRUG; Name: Flovent Diskus® 250 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Flovent Diskus® 500 mcg; Assigned to Arm(s): Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Advair Diskus® 100/50 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Advair Diskus® 250/50 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8
C: Arm Label: Fluticasone Furoate/Vilanterol 100/25 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler, Drug: Placebo inhalation powder via ACCUHALER/DISKUS inhaler | Arm Label: Fluticasone Propionate/Salmeterol 250/50 mcg; Type: EXPERIMENTAL; Interventions: Drug: Placebo inhalation powders via ELLIPTA inhaler, Drug: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler | Arm Label: Fluticasone Propionate 250 mcg; Type: EXPERIMENTAL; Interventions: Drug: Placebo inhalation powders via ELLIPTA inhaler, Drug: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler | Intervention Type: DRUG; Name: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler; Assigned to Arm(s): Fluticasone Furoate/Vilanterol 100/25 mcg | Intervention Type: DRUG; Name: Placebo inhalation powders via ELLIPTA inhaler; Assigned to Arm(s): Fluticasone Propionate 250 mcg, Fluticasone Propionate/Salmeterol 250/50 mcg | Intervention Type: DRUG; Name: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler; Assigned to Arm(s): Fluticasone Propionate/Salmeterol 250/50 mcg | Intervention Type: DRUG; Name: Placebo inhalation powder via ACCUHALER/DISKUS inhaler; Assigned to Arm(s): Fluticasone Furoate/Vilanterol 100/25 mcg | Intervention Type: DRUG; Name: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler; Assigned to Arm(s): Fluticasone Propionate 250 mcg
D: Arm Label: FS MDPI 200 / 12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: Albuterol/salmeterol HFA MDI | Arm Label: FS MDPI 100 / 12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: Albuterol/salmeterol HFA MDI | Arm Label: Fp MDPI 200 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: Albuterol/salmeterol HFA MDI | Arm Label: Fp MDPI 100 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: Albuterol/salmeterol HFA MDI | Arm Label: Placebo MDPI; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo MDPI, Drug: Albuterol/salmeterol HFA MDI | Intervention Type: DRUG; Name: FS MDPI; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 200 / 12.5 mcg | Intervention Type: DRUG; Name: Fp MDPI; Assigned to Arm(s): Fp MDPI 100 mcg, Fp MDPI 200 mcg | Intervention Type: DRUG; Name: Placebo MDPI; Assigned to Arm(s): Placebo MDPI | Intervention Type: DRUG; Name: Albuterol/salmeterol HFA MDI; Assigned to Arm(s): FS MDPI 100 / 12.5 mcg, FS MDPI 200 / 12.5 mcg, Fp MDPI 100 mcg, Fp MDPI 200 mcg, Placebo MDPI

Answer: A